cancerGRACE
GRACEcast - Discussions with the Global Resource for Advancing Cancer EducationEpisodes
Episodes of GRACEcast
Mark All
Search Episodes...
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
Dr. Joshua Reuss examines data on neoadjuvant targeted therapy.
Dr. Joshua Reuss gives a brief description of the ongoing Alina trial for patients with ALK+ NSCLC.
Dr. Puneeth Iyengar discusses the concept of using local therapy as an additional treatment for limited metastatic NSCLC, including Stereotactic Body Radiation Therapy (SBRT).
Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.
Dr. Joshua Reuss discusses treatment options for patients with locally advanced NSCLC, and how to proceed while waiting for trial data.
Dr. Puneeth Iyengar discusses local therapy options for patients with metastatic disease who have received a front line therapy.
Dr. Joshua Reuss discusses what the patient can do to advocate for themselves during treatment.
Dr. Joshua Reuss discusses considerations and questions for targeted therapy before surgery.
Dr. Puneeth Iyengar discusses local therapy treatment options for patients who have oligoprogressive disease.
Dr. Puneeth Iyengar examines what has been learned from studies, what still remains unanswered, and future directions of local therapy treatments for patients with NSCLC.
Dr. Puneeth Iyengar looks at current statistics for methods of adding to targeted therapy, as well as giving an overview of biology in treatment.
Dr. Rana McKay discusses why it's crucial to get a prostate cancer screening.
डॉ. अलंकृता तनेजा ट्रांसजेंडर मरीजों में देखे जाने वाले सामान्य परामर्श मुद्दों पर चर्चा करती हैं, और सही मॉनिटरिंग का महत्व बताती हैं।(Dr. Alankrita Taneja discusses common consultation issues seen in transgender patients, and the importance o
डॉ. अलंकृता तनेजा टेस्टोस्टेरोन थेरेपी और इसके साथ आने वाले जोखिमों पर चर्चा करती हैं, जिसमें द्वितीय एरिथ्रोसाइटोसिस भी शामिल है।(Dr. Alankrita Taneja discusses testosterone therapy and the risks that come with it, including secondary erythroc
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us